ResQCPR System
ZOLL MEDICAL CORPORATION · Decision date Aug 27, 2026
What did the FDA decide?
FDA records P110024/S007 as a supplement to PMA P110024, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Aug 27, 2026.
FDA approval order statement
a component supplier manufacturing site change for the Timing Assist Light Board
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Aug 27, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P110024/S007
- Regulatory pathway
- PMA supplement
- Applicant
- ZOLL MEDICAL CORPORATION
- Product code
- PIZ
- Decision code
- OK30
- Decision date
- Aug 27, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Combination compression/decompression manual chest pump with impedance respiratory valve.
- Applicant
- ZOLL MEDICAL CORPORATION
- Product code
- PIZ
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P110024/S007 received
Application receipt date recorded by FDA.
P110024/S007 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P110024. View FDA’s full supplement list.
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
ZOLL MEDICAL CORPORATION
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 269 Mill Rd., Chelsmford, MA, 01824
Sources and methodology
- Original FDA record: P110024/S007
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records